GeNeuro (FRA:GEM) OCF Yield %: 0.00 (As of Jul. 06, 2026)


FRA:GEM GeNeuro SA FRA:GEM
8 GF Score
Price €0.03
View Full Analysis

What is GeNeuro OCF Yield %?

GeNeuro FRA:GEM 8 OCF Yield % is 0.00 as of Jul. 06, 2026. GuruFocus rates FRA:GEM with a GF Score™ of 8/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, GeNeuro's Trailing 12-Month Cash Flow from Operations is €-10.15 Mil, and Market Cap is €0.91 Mil. Therefore, GeNeuro's OCF Yield % for today is 0.00%.

The historical rank and industry rank for GeNeuro's OCF Yield % or its related term are showing as below:


FRA:GEM's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -7.975
* Ranked among companies with meaningful OCF Yield % only.

GeNeuro's OCF Margin % for the quarter that ended in Dec. 2023 was %.

GeNeuro OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

GeNeuro OCF Yield % Related Terms

GeNeuro OCF Yield % Historical Data

* Premium members only.

The historical data trend for GeNeuro's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GeNeuro OCF Yield % Chart

GeNeuro Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.54 -12.94 -8.95 -34.03 -43.19

GeNeuro Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.11 -8.54 -54.94 -24.39 -46.20
FRA:GEM
8GF Score
GeNeuro SA FRA:GEM
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GeNeuro OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

GeNeuro's OCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-10.147 / 23.492964
=-43.19%

GeNeuro's annualized OCF Yield % for the quarter that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-5.427 * 2 / 23.492964
=-46.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
GeNeuro (FRA:GEM) has a OCF Yield % of 0.00 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on GeNeuro and its competitors.
Is GeNeuro's OCF Yield % too high?
GeNeuro's current OCF Yield % is 0.00. Overall, GeNeuro has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does GeNeuro's OCF Yield % compare to VRTX and REGN?
GeNeuro's OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on GeNeuro and its competitors. GeNeuro's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GeNeuro stock overvalued right now?
GeNeuro (FRA:GEM) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. GeNeuro's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For GeNeuro (FRA:GEM), the current OCF Yield % is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GeNeuro Business Description

Address 3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
8GF Score

Get the complete analysis for FRA:GEM

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price